1. Home
  2. UBXG vs MNOV Comparison

UBXG vs MNOV Comparison

Compare UBXG & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • MNOV
  • Stock Information
  • Founded
  • UBXG 2018
  • MNOV 2000
  • Country
  • UBXG China
  • MNOV United States
  • Employees
  • UBXG N/A
  • MNOV N/A
  • Industry
  • UBXG
  • MNOV Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • MNOV Health Care
  • Exchange
  • UBXG Nasdaq
  • MNOV Nasdaq
  • Market Cap
  • UBXG 60.1M
  • MNOV 65.7M
  • IPO Year
  • UBXG 2024
  • MNOV 2005
  • Fundamental
  • Price
  • UBXG $1.96
  • MNOV $1.22
  • Analyst Decision
  • UBXG
  • MNOV Strong Buy
  • Analyst Count
  • UBXG 0
  • MNOV 2
  • Target Price
  • UBXG N/A
  • MNOV $7.00
  • AVG Volume (30 Days)
  • UBXG 597.6K
  • MNOV 64.9K
  • Earning Date
  • UBXG 01-01-0001
  • MNOV 11-12-2025
  • Dividend Yield
  • UBXG N/A
  • MNOV N/A
  • EPS Growth
  • UBXG N/A
  • MNOV N/A
  • EPS
  • UBXG N/A
  • MNOV N/A
  • Revenue
  • UBXG $39,603,353.00
  • MNOV $134,599.00
  • Revenue This Year
  • UBXG N/A
  • MNOV N/A
  • Revenue Next Year
  • UBXG N/A
  • MNOV N/A
  • P/E Ratio
  • UBXG N/A
  • MNOV N/A
  • Revenue Growth
  • UBXG N/A
  • MNOV N/A
  • 52 Week Low
  • UBXG $1.84
  • MNOV $1.13
  • 52 Week High
  • UBXG $13.60
  • MNOV $2.55
  • Technical
  • Relative Strength Index (RSI)
  • UBXG 31.96
  • MNOV 37.71
  • Support Level
  • UBXG $2.60
  • MNOV $1.25
  • Resistance Level
  • UBXG $2.96
  • MNOV $1.38
  • Average True Range (ATR)
  • UBXG 0.30
  • MNOV 0.04
  • MACD
  • UBXG -0.08
  • MNOV -0.01
  • Stochastic Oscillator
  • UBXG 8.80
  • MNOV 0.00

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Share on Social Networks: